Adtalem Global Education’s (CVSA) “Outperform” Rating Reiterated at Barrington Research

Posted by ABMN Staff on Mar 5th, 2026

Barrington Research restated their outperform rating on shares of Adtalem Global Education (NYSE:CVSA – Free Report) in a report published on Monday,Benzinga reports. Barrington Research currently has a $170.00 price target on the stock.

CVSA has been the topic of several other reports. Zacks Research raised Adtalem Global Education from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, February 24th. Weiss Ratings assumed coverage on Adtalem Global Education in a research note on Wednesday, February 25th. They issued a “hold (c+)” rating for the company. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $170.00.

Check Out Our Latest Report on CVSA

Adtalem Global Education Price Performance

Shares of Adtalem Global Education stock opened at $100.77 on Monday. The company has a current ratio of 0.68, a quick ratio of 0.68 and a debt-to-equity ratio of 0.37. The firm has a market cap of $3.48 billion, a price-to-earnings ratio of 13.23, a P/E/G ratio of 0.87 and a beta of 0.72. Adtalem Global Education has a 12-month low of $86.26 and a 12-month high of $156.26.

Adtalem Global Education (NYSE:CVSA – Get Free Report) last posted its earnings results on Wednesday, January 28th. The company reported $2.43 EPS for the quarter. Adtalem Global Education had a net margin of 13.41% and a return on equity of 20.24%. The firm had revenue of $503.39 million during the quarter.

Adtalem Global Education Company Profile

(Get Free Report)

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.